These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6311128)

  • 61. Human cerebrospinal fluid pharmacokinetics and treatment of bacterial meningitis with ceftizoxime.
    Cable D; Edralin G; Overturf GD
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():121-7. PubMed ID: 6295997
    [No Abstract]   [Full Text] [Related]  

  • 62. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
    Kim KS; Anthony BF
    Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Seven days of ceftriaxone therapy is as effective as ten days' treatment for bacterial meningitis.
    Lin TY; Chrane DF; Nelson JD; McCracken GH
    JAMA; 1985 Jun; 253(24):3559-63. PubMed ID: 3889396
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group.
    Schmutzhard E; Williams KJ; Vukmirovits G; Chmelik V; Pfausler B; Featherstone A
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():85-97. PubMed ID: 8543502
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis.
    Odio CM; Faingezicht I; Paris M; Nassar M; Baltodano A; Rogers J; Sáez-Llorens X; Olsen KD; McCracken GH
    N Engl J Med; 1991 May; 324(22):1525-31. PubMed ID: 2027357
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The influence of dosing schedules and cerebrospinal fluid bactericidal activity on the therapy of bacterial meningitis.
    Scheld WM; Tauber MG; Zak O; Sande MA
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():303-12. PubMed ID: 3980333
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cefotaxime treatment of gram-negative enteric meningitis in infants and children.
    Jacobs RF
    Drugs; 1988; 35 Suppl 2():185-9. PubMed ID: 3293975
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Determination of cefotaxime and desacetylcefotaxime in cerebrospinal fluid by solid-phase extraction and high-performance liquid chromatography.
    Bafeltowska JJ; Buszman E; Mandat K; Hawranek J
    J Chromatogr A; 2002 Nov; 976(1-2):249-54. PubMed ID: 12462616
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Host defense and antimicrobial therapy in adult gram-negative bacillary meningitis.
    Rahal JJ; Simberkoff MS
    Ann Intern Med; 1982 Apr; 96(4):468-74. PubMed ID: 7039444
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.
    Landesman SH; Corrado ML; Shah PM; Armengaud M; Barza M; Cherubin CE
    Am J Med; 1981 Oct; 71(4):693-703. PubMed ID: 6269429
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bacterial meningitis in children: diagnosis and therapy. A review of recent developments.
    Stutman HR; Marks MI
    Clin Pediatr (Phila); 1987 Sep; 26(9):431-8. PubMed ID: 3304773
    [No Abstract]   [Full Text] [Related]  

  • 72. Successful treatment of meningitis with cefotaxime in an adult.
    Jones DK; Luksza AR
    J Infect; 1983 Nov; 7(3):270-1. PubMed ID: 6319499
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Unusual presentation of primary klebsiella meningitis: successful treatment with cefotaxime.
    Sandyk R; Brennan MJ
    Postgrad Med J; 1983 Apr; 59(690):256-7. PubMed ID: 6306628
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child.
    Skogen PG; Kolmannskog S; Bergh K
    Clin Microbiol Infect; 2001 Jan; 7(1):39-42. PubMed ID: 11284946
    [No Abstract]   [Full Text] [Related]  

  • 75. Penetration of aztreonam into cerebrospinal fluid and brain of noninfected rabbits and rabbits with experimental meningitis caused by Pseudomonas aeruginosa.
    Strausbaugh LJ; Bodem CR; Laun PR
    Antimicrob Agents Chemother; 1986 Nov; 30(5):701-4. PubMed ID: 3099641
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms.
    Francke EL; Neu HC
    Am J Med; 1981 Sep; 71(3):435-42. PubMed ID: 6269426
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A comparison of ampicillin-cefotaxime and ampicillin-chloramphenicol in childhood bacterial meningitis: an experience in 55 patients.
    Lapointe JR; Béliveau C; Chicoine L; Joncas JH
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():167-80. PubMed ID: 6094437
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis.
    Wolff M; Regnier B; Daldoss C; Nkam M; Vachon F
    Antimicrob Agents Chemother; 1984 Sep; 26(3):289-91. PubMed ID: 6594970
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Levels of cefotaxime in body fluids and tissues: a review.
    Novick WJ
    Rev Infect Dis; 1982; 4 Suppl():S346-53. PubMed ID: 6294783
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neonatal gram negative meningitis: a 10-year review, with reference to outcome and relapse of infection.
    Anderson SG; Gilbert GL
    J Paediatr Child Health; 1990 Aug; 26(4):212-6. PubMed ID: 2257183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.